#Amitiza
Related Pages (3)
Attorneys at Hagens Berman Announce $474M Win in Amitiza Jury Trial Against Takeda
BOSTON – A class-action lawsuit against Takeda Pharmaceuticals USA Inc. on behalf of direct purchasers of Amitiza and its generic equivalents ended today when a jury returned a verdict finding the pha
hbsslaw.com•May 19, 2026
Takeda Hit With $885 Million Verdict in Pay-for-Delay Case (2)
A federal jury ordered Takeda Pharmaceuticals Co. Ltd. to pay $884.9 million in damages for violating antitrust law by delaying the generic version of its branded Amitiza drug through an illegal agree
news.bloomberglaw.com•May 19, 2026
Takeda Pharmaceutical Faces $885 Million Verdict in Antitrust Case
A Boston jury has delivered a major blow to Takeda Pharmaceutical, holding the company accountable for $885 million in damages for its role in delaying a generic version of the constipation drug Amiti
devdiscourse.com•May 19, 2026